Welcome to our dedicated page for Aveanna Healthcare Holdings news (Ticker: AVAH), a resource for investors and traders seeking the latest updates and insights on Aveanna Healthcare Holdings stock.
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) is described as a diversified home care platform focused on medically complex, high-cost patient populations, with headquarters in Atlanta, Georgia and locations in 38 states. The AVAH news page on Stock Titan aggregates company press releases and market updates that explain how Aveanna delivers pediatric and adult nursing, therapy, home health, hospice, and medical product services in home and community settings.
Visitors to this page can review Aveanna’s own announcements on topics such as updated full year financial guidance, preliminary and final quarterly results, and commentary on non-GAAP measures like EBITDA, Adjusted EBITDA, and Normalized Adjusted EBITDA. News items also cover participation in healthcare and finance conferences, including events hosted by financial institutions, where the company’s management presents to investors and holds one-on-one meetings.
Other Aveanna releases describe capital markets activity and financing developments, such as secondary offerings of common stock by existing stockholders and amendments to credit facilities and term loans. These updates provide context on the company’s capital structure, refinancing transactions, and relationships with lenders and underwriters.
Because Aveanna positions its services as a high quality, lower cost alternative to prolonged hospitalization, news about its financial performance, strategic financing actions, and investor presentations can be relevant to those tracking trends in home-based care for medically fragile and chronically ill children and adults. For ongoing coverage of AVAH, investors and observers can use this page to follow the company’s reported milestones, regulatory disclosures referenced in press releases, and other public communications.
Aveanna Healthcare Holdings (NASDAQ: AVAH) has announced its participation in the Stephens Annual Investment Conference. The company's management team will be attending virtually on Friday, November 22, 2024. During the conference, Aveanna's executives will be hosting one-on-one meetings with investors.
This virtual attendance at the investment conference provides an opportunity for Aveanna to engage with potential investors and discuss the company's performance, strategies, and future prospects. The one-on-one format allows for more focused and personalized interactions between the company's management and interested investors.
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) has announced its schedule for releasing third quarter 2024 financial results. The company will disclose its Q3 results before the market opens on Thursday, November 7, 2024. This will be followed by a conference call at 10:00 a.m. Eastern Time on the same day.
Investors can access the conference call by dialing 1-877-407-0789 (US) or 1-201-689-8562 (international). A replay will be available three hours after the call until November 14, 2024, accessible via 1-844-512-2921 (US) or 1-412-317-6671 (international). The passcode for both the live call and replay is 13748484.
Additionally, a simultaneous webcast of the conference call will be available on the Investor Relations section of Aveanna's website at https://ir.aveanna.com/. The online replay will remain accessible for one week following the call.
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) has announced its participation in the Deutsche Bank Annual Leveraged Finance Conference on September 24, 2024, in Scottsdale, AZ. The company's management team will be hosting one-on-one investor meetings during the event.
Aveanna Healthcare, headquartered in Atlanta, Georgia, operates in 33 states across the US. The company offers a wide range of healthcare services for both pediatric and adult patients, including:
- Nursing and rehabilitation services
- Occupational nursing in schools
- Therapy services
- Day treatment centers for medically fragile patients
- Home health and hospice services
- Enteral nutrition delivery
- Case management services
- Respite healthcare services
Aveanna's services aim to provide high-quality, cost-effective alternatives to prolonged hospitalization.
Aveanna Healthcare Holdings (NASDAQ: AVAH) reported strong Q2 2024 results, with revenue increasing 7.0% to $505.0 million and Adjusted EBITDA growing 27.3% to $45.6 million compared to Q2 2023. The company's gross margin increased 1.9% to $158.3 million. Net income was $13.9 million, down from $25.6 million in the prior year period. Based on these positive results, Aveanna has raised its full-year 2024 guidance, projecting revenue greater than $1,985 million and Adjusted EBITDA exceeding $158 million. The company attributes its success to ongoing strategic transformation efforts and enhanced payor partnerships, allowing for expanded care delivery and investment in caregivers.
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) has announced the release date for its second quarter 2024 earnings report. The company will disclose its results before the market opens on Thursday, August 8, 2024. Following the release, Aveanna will host a conference call at 10:00 a.m. Eastern Time on the same day.
Investors can access the call by dialing 1-877-407-0789 (US) or 1-201-689-8562 (international). A replay will be available for a week, accessible by dialing 1-844-512-2921 (US) or 1-412-317-6671 (international) with the passcode 13746737. Additionally, a simultaneous webcast will be available on the company's Investor Relations website at https://ir.aveanna.com/.
Aveanna Healthcare Holdings announced its participation in two key healthcare conferences: the UBS Healthcare Services Cape Cod Summit on June 4, 2024, and the Jefferies Global Healthcare Conference on June 5, 2024. The management team will host one-on-one investor meetings at both events, and a fireside chat at the Jefferies conference, which will be webcast live and available for replay. These engagements aim to increase investor visibility and communication.
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) announced first quarter 2024 financial results, showing a revenue of $490.7 million, a 5.2% increase over the prior year, with a net loss of $11.2 million. Adjusted EBITDA increased by 22.5% to $34.9 million. Full year 2024 revenue guidance was raised to over $1,970 million, with Adjusted EBITDA guidance raised to over $150 million. The company emphasized enhancing payor partnerships, investing in caregivers, and expanding care delivery as key factors driving their growth and success.
Aveanna Healthcare Holdings Inc. announced its participation at the Barclays Leveraged Finance Conference in Austin, TX on May 21, 2024. Aveanna's management team will host investor meetings at the conference.
Aveanna Healthcare Holdings Inc. announced its participation at the RBC Capital Markets Global Healthcare Conference in New York on May 14, 2024. The management team will conduct investor meetings and a fireside chat, with a webcast available on the company's Investor Relations website.
Summary not available.